$316 Million is the total value of First Light Asset Management, LLC's 52 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 16.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NEO | Sell | NEOGENOMICS INC | $26,800,000 | +11.6% | 2,407,930 | -10.1% | 8.49% | +5.4% |
| ATRC | Buy | ATRICURE INC | $23,125,000 | -0.5% | 1,033,736 | +7.8% | 7.32% | -6.1% |
| IMMU | Sell | IMMUNOMEDICS INC | $18,335,000 | +1.4% | 1,311,514 | -36.0% | 5.81% | -4.3% |
| ARRY | Buy | ARRAY BIOPHARMA INC | $18,074,000 | +277.7% | 1,469,461 | +157.1% | 5.72% | +256.6% |
| HBIO | Buy | HARVARD BIOSCIENCE INC | $15,436,000 | +69.5% | 4,116,282 | +15.2% | 4.89% | +59.9% |
| OMCL | Buy | OMNICELL INC | $15,224,000 | +26.9% | 298,219 | +7.2% | 4.82% | +19.8% |
| MODN | Buy | MODEL N INC | $12,733,000 | +126.2% | 851,708 | +101.2% | 4.03% | +113.4% |
| NKTR | Buy | NEKTAR THERAPEUTICS | $12,077,000 | +31.4% | 503,193 | +7.0% | 3.82% | +24.0% |
| ENTL | Buy | ENTELLUS MEDICAL INC | $11,680,000 | +37.6% | 632,737 | +23.5% | 3.70% | +29.9% |
| SHPG | Buy | SHIRE PLC | $11,404,000 | -0.7% | 74,470 | +7.1% | 3.61% | -6.3% |
| TLGT | Buy | TELIGENT INC | $9,953,000 | +14.7% | 1,483,343 | +56.4% | 3.15% | +8.3% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $9,448,000 | +7.1% | 562,377 | +7.2% | 2.99% | +1.1% |
| LGND | Buy | LIGAND PHARMACEUTICALS INC | $8,625,000 | +13.5% | 63,346 | +1.2% | 2.73% | +7.1% |
| MDCO | Buy | MEDICINES COMPANY | $8,160,000 | +55.0% | 220,300 | +59.0% | 2.58% | +46.2% |
| HALO | Buy | HALOZYME THERAPEUTICS INC | $7,744,000 | +45.0% | 445,846 | +7.0% | 2.45% | +36.8% |
| VCYT | Buy | VERACYTE INC | $7,384,000 | +17.5% | 841,959 | +11.6% | 2.34% | +10.9% |
| HRTX | Buy | HERON THERAPEUTICS INC | $6,355,000 | +24.9% | 393,505 | +7.1% | 2.01% | +17.9% |
| DVAX | New | DYNAVAX TECHNOLOGIES CORP | $5,889,000 | – | 273,930 | +100.0% | 1.86% | – |
| KTWO | Buy | K2M GROUP HOLDINGS INC | $5,836,000 | -11.8% | 275,173 | +1.4% | 1.85% | -16.7% |
| NVRO | Buy | NEVRO CORP | $5,444,000 | +23.2% | 59,905 | +0.9% | 1.72% | +16.3% |
| QDEL | Buy | QUIDEL CORP | $5,373,000 | +166.8% | 122,509 | +65.1% | 1.70% | +151.6% |
| GMED | New | GLOBUS MEDICAL INC | $5,320,000 | – | 179,016 | +100.0% | 1.68% | – |
| XENT | Sell | INTERSECT ENT INC | $5,302,000 | -30.7% | 170,197 | -37.8% | 1.68% | -34.6% |
| NXTM | Buy | NXSTAGE MEDICAL INC | $5,067,000 | +17.8% | 183,592 | +7.0% | 1.60% | +11.2% |
| BLUE | Buy | BLUEBIRD BIO INC | $4,956,000 | +39.6% | 36,085 | +6.8% | 1.57% | +31.7% |
| TECH | Buy | BIO TECHNE CORP | $4,673,000 | +4.1% | 38,654 | +1.2% | 1.48% | -1.7% |
| HSTM | Buy | HEALTHSTREAM INC | $4,656,000 | -4.9% | 199,243 | +7.1% | 1.47% | -10.3% |
| LHCG | Sell | LHC GROUP INC | $4,587,000 | -26.5% | 64,672 | -29.6% | 1.45% | -30.6% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $3,561,000 | +19.5% | 23,421 | +1.3% | 1.13% | +12.9% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $2,969,000 | +3.6% | 31,902 | +1.1% | 0.94% | -2.3% |
| MGNX | Buy | MACROGENICS INC | $2,803,000 | +160.0% | 151,670 | +146.5% | 0.89% | +145.3% |
| STRM | Sell | STREAMLINE HEALTH SOLUTIONS | $2,588,000 | +36.5% | 1,760,706 | -0.6% | 0.82% | +28.9% |
| IBB | ISHARES NASDAQ BIOTECHNOLOGY ETFetf | $2,367,000 | +7.6% | 7,097 | 0.0% | 0.75% | +1.6% | |
| ENZ | Sell | ENZO BIOCHEM INC | $2,362,000 | -46.9% | 225,616 | -44.0% | 0.75% | -49.9% |
| CDXS | Buy | CODEXIS INC | $2,294,000 | +53.0% | 344,990 | +25.5% | 0.73% | +44.3% |
| IRIX | Buy | IRIDEX CORP | $2,238,000 | +124.5% | 238,795 | +136.8% | 0.71% | +112.3% |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $2,155,000 | +0.8% | 42,511 | +1.2% | 0.68% | -4.9% |
| CELG | Buy | CELGENE CORP | $2,020,000 | +13.5% | 13,856 | +1.1% | 0.64% | +7.2% |
| LMAT | Buy | LEMAITRE VASCULAR INC | $1,752,000 | +21.4% | 46,816 | +1.3% | 0.56% | +14.7% |
| PSCH | POWERSHARES S&P SMALLCAP HEALTH CARE ETFetf | $1,605,000 | +5.7% | 17,285 | 0.0% | 0.51% | -0.4% | |
| ALKS | Buy | ALKERMES PLC | $1,530,000 | -11.1% | 30,087 | +1.3% | 0.48% | -16.3% |
| XLV | HEALTH CARE SELECT SECTOR SPDR ETFetf | $1,491,000 | +3.2% | 18,241 | 0.0% | 0.47% | -2.7% | |
| IHI | ISHARES US MEDICAL DEVICES ETFetf | $1,266,000 | +0.2% | 7,580 | 0.0% | 0.40% | -5.4% | |
| XBI | SPDR S&P BIOTECH ETFetf | $822,000 | +12.1% | 9,499 | 0.0% | 0.26% | +5.7% | |
| ABBV | ABBVIE | $370,000 | +22.5% | 4,159 | 0.0% | 0.12% | +15.8% | |
| SNY | SANOFI-SYNTHELABO | $335,000 | +4.0% | 6,720 | 0.0% | 0.11% | -1.9% | |
| PFE | PFIZER INC | $306,000 | +6.6% | 8,558 | 0.0% | 0.10% | +1.0% | |
| NVS | NOVARTIS A G | $307,000 | +3.0% | 3,572 | 0.0% | 0.10% | -3.0% | |
| JNJ | JOHNSON AND JOHNSON | $284,000 | -1.7% | 2,183 | 0.0% | 0.09% | -7.2% | |
| MRK | MERCK & CO INC | $275,000 | 0.0% | 4,294 | 0.0% | 0.09% | -5.4% | |
| DYNT | Buy | DYNATRONICS CORP | $231,000 | -17.5% | 102,024 | +2.0% | 0.07% | -22.3% |
| AMGN | New | AMGEN INC | $207,000 | – | 1,105 | +100.0% | 0.07% | – |
| TEAR | Exit | TEARLAB CORP | $0 | – | -420,066 | -100.0% | -0.24% | – |
| NSTG | Exit | NANOSTRING TECHNOLOGIES INC | $0 | – | -114,702 | -100.0% | -0.64% | – |
| AMED | Exit | AMEDISYS INC | $0 | – | -92,535 | -100.0% | -1.95% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -92,761 | -100.0% | -2.48% | – |
| SPNC | Exit | SPECTRANETICS CORP | $0 | – | -217,637 | -100.0% | -2.80% | – |
| AKRXQ | Exit | AKORN INC | $0 | – | -732,462 | -100.0% | -8.24% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.